Synthetic process of anti-hyperglycemic drug intermediate R-3-amino-piperidine dihydrochloride
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 苏州汉德创宏生化科技有限公司
- Publication Date
- 2019-10-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical intermediates, in particular to a synthesis process of R-3-amino-piperidine dihydrochloride, an antihyperglycemic pharmaceutical intermediate. Background technique
[0002] R-3-amino-piperidine dihydrochloride is an important drug intermediate, and the synthesis of linagliptin, alogliptin, linagliptin, etc. requires the use of R-3-amino-piperidine dihydrochloride Hydrochloride is used as an intermediate, so the synthesis of this compound is widely used in the field of medicine.
[0003] The traditional methods of synthesizing R-3-amino-piperidine dihydrochloride have obvious shortcomings. For example, the reduction reaction of some relatively complex precursor molecules containing R-3-amino-piperidine framework is carried out to obtain R-3-amino-piperidine dihydrochloride, and the reaction in the conversion requires relatively high temperature and oxidant, or The use of highly toxic pyridine deriva...